Zoom Video Conferencing is a popular platform that enables high-quality virtual meetings, webinars, and collaboration with features like screen sharing, breakout rooms, and recording, making remote communication seamless and efficient.
View Companies using Zoom Video ConferencingZoom is a leading video conferencing platform that enables virtual meetings, webinars, and collaboration with high-quality audio and video, screen sharing, and chat features, making remote communication seamless and efficient.
View Companies using ZoomThe Financial Conduct Authority (FCA) is the UK's regulatory body overseeing financial markets, ensuring consumer protection, fair competition, and the integrity of financial services.
View Companies using Financial Conduct AuthorityConvertro is a marketing analytics platform that provides insights into customer journeys and attribution, helping businesses optimize campaigns and improve ROI through data-driven decision-making.
View Companies using ConvertroNetmining is an AI-powered audience insights platform that analyzes consumer data to deliver targeted advertising solutions, optimize marketing strategies, and enhance brand engagement through advanced data analytics and real-time insights.
View Companies using NetminingAccuen is a programmatic advertising platform by The Trade Desk that enables marketers to efficiently buy, optimize, and manage digital ad campaigns across multiple channels, maximizing reach and ROI through data-driven automation.
View Companies using AccuenDaniel Deweldon is the CEO of Volition. To contact Daniel Deweldon email at [email protected].
The decision makers in Volition are Alexandra Thompson, Emmanuel Demillecamps, Francis Brady, etc. Click to Find Volition decision makers emails.
Volition specializes in the development of innovative blood tests that leverage epigenetic biomarkers to diagnose and monitor various diseases, particularly cancer. Our services include comprehensive diagnostic solutions that help healthcare providers identify disease presence and progression, enabling timely and effective treatment decisions.
Volition's technology utilizes advanced epigenetic analysis to detect changes in DNA that are indicative of cancer. By analyzing these epigenetic markers in blood samples, our tests can provide earlier and more accurate diagnoses compared to traditional methods, potentially leading to better patient outcomes and personalized treatment plans.
While Volition primarily focuses on cancer diagnostics, our epigenetic technology has the potential to be applied to a wide range of diseases. Our ongoing research aims to expand the scope of our tests to include various life-altering conditions, enhancing our ability to provide critical insights into patient health.
Volition's diagnostic solutions are designed for use by healthcare providers, oncologists, and researchers. Patients undergoing cancer treatment or those at risk for developing cancer can particularly benefit from our tests, as they provide valuable information that can guide treatment decisions and monitor disease progression.
Yes, Volition's technology is grounded in extensive scientific research and development. Our team of experts continuously conducts studies to validate the efficacy of our epigenetic tests, ensuring that our diagnostic solutions are reliable and based on the latest advancements in the field of epigenetics.
To learn more about Volition's services and stay informed about our latest research and product developments, you can visit our website at http://www.volition.com. Additionally, consider subscribing to our newsletter or following us on social media for real-time updates and insights into our work in the field of epigenetics and cancer diagnostics.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.